Are postnatal steroids ever justified to treat severe bronchopulmonary dysplasia?
- 1 September 2007
- journal article
- review article
- Published by BMJ in Archives of Disease in Childhood: Fetal & Neonatal
- Vol. 92 (5) , F334-F337
- https://doi.org/10.1136/adc.2006.106583
Abstract
Current evidence does not favour use of corticosteroids as neurological side effects may outweigh the benefits of treatment, except perhaps in critically ill infants with respiratory failureKeywords
This publication has 29 references indexed in Scilit:
- Extremely Low Birthweight Neonates with Protracted Ventilation: Mortality and 18-Month Neurodevelopmental OutcomesThe Journal of Pediatrics, 2005
- Pretreatment cortisol values may predict responses to hydrocortisone administration for the prevention of bronchopulmonary dysplasia in high-risk infantsThe Journal of Pediatrics, 2005
- Impact of Postnatal Systemic Corticosteroids on Mortality and Cerebral Palsy in Preterm Infants: Effect Modification by Risk for Chronic Lung DiseasePediatrics, 2005
- Prophylaxis of Early Adrenal Insufficiency to Prevent Bronchopulmonary Dysplasia: A Multicenter TrialPediatrics, 2004
- Outcomes at School Age after Postnatal Dexamethasone Therapy for Lung Disease of PrematurityNew England Journal of Medicine, 2004
- Postnatal Corticosteroids for Preterm Infants — Do What We Say, Not What We DoNew England Journal of Medicine, 2004
- Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infantsPublished by Wiley ,2003
- Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infantsPublished by Wiley ,2003
- Antenatal Glucocorticoid Treatment and Cystic Periventricular Leukomalacia in Very Premature InfantsNew England Journal of Medicine, 1999
- Randomized Placebo-controlled Trial of a 42-Day Tapering Course of Dexamethasone to Reduce the Duration of Ventilator Dependency in Very Low Birth Weight Infants: Outcome of Study Participants at 1-Year Adjusted AgePediatrics, 1999